2 completed, 1 terminated. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 2, Terminated 1 |
Follow GP-Pharm: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Leuprolide Acetate 22.5 mg Depot in Treatment of Prostate Cancer Leuprolide acetate 22.5 mg depot, GP-Pharm SA - Prostate Cancer | Phase 3 | Completed | GP-Pharm | 163 | 2011-09-01 | 2017-03-03 |
| Efficacy and Safety Study of a New Leuprolide Acetate 17 mg Depot to Treat Prostate Cancer Patients leuprolide acetate - Prostate Cancer | Phase 3 | Terminated | GP-Pharm | 20 | 2008-05-01 | 2010-09-09 |
| Leuprolide Acetate 3.75 mg Depot to Treat Prostate Cancer leuprolide acetate - Prostate Cancer | Phase 3 | Completed | GP-Pharm | 120 | 2005-09-01 | 2007-11-14 |
Prostatic Neoplasms (3) · Neoplasms (1)
Leuprolide (3)
United States (3) · Austria (1) · Czechia (1) · Germany (1) · Hungary (1) · Italy (1) · Slovakia (1) · Spain (1) · United Kingdom (1)